PERCEPTIVE ADVISORS LLC
Q1 2022 13F-HR Holdings
Net value change ($000)
-1,484,730
(-22.9%)
New positions
15
Sold out positions
22
Turnover %
12.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AGILE THERAPEUTICS INC | 168,053 | 1616.8% |
| CinCor Pharma, Inc. | 40,677 | NEW |
| Global Blood Therapeutics, Inc. | 33,857 | 33.5% |
| NEVRO CORP | 32,644 | 1755.1% |
| PEN | 31,896 | NEW |
| ALNY | 29,405 | NEW |
| Axonics, Inc. | 21,360 | NEW |
| MDGL | 19,983 | 272.9% |
| AMLX | 18,942 | NEW |
| PRCT | 18,855 | 56.8% |
Top Reduces (Value $000, Stocks/ETFs)
| Mirati Therapeutics, Inc. | -285,956 | -59.4% |
| LIANY | -137,984 | -39.8% |
| BMRN | -104,253 | -100.0% |
| BBIO | -79,938 | -67.2% |
| MGTX | -68,751 | -41.7% |
| Landos Biopharma, Inc. | -49,442 | -69.3% |
| ARENA PHARMACEUTICALS INC | -46,470 | -100.0% |
| RAPT | -45,958 | -42.7% |
| FOLD | -45,808 | -14.9% |
| SpringWorks Therapeutics, Inc. | -45,038 | -15.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|